Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine With or Without Capecitabine in Advanced Pancreatic Cancer
NCT00032175Phase 3Completed
- Sponsor
- Cancer Research UK
- Start
- Apr 2002
- Modality
- DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors, RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of capecitabine in pancreatic cancer (PC), sponsored by Cancer Research UK. Started Apr 2002; status: completed.
02
Drugs
capecitabine
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT00032175.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00032175.